These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38596290)

  • 1. Gut microbiota composition is associated with the efficacy of Delta-24-RGDOX in malignant gliomas.
    Meléndez-Vázquez NM; Nguyen TT; Fan X; López-Rivas AR; Fueyo J; Gomez-Manzano C; Godoy-Vitorino F
    Mol Ther Oncol; 2024 Mar; 32(1):200787. PubMed ID: 38596290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant Therapy with Oncolytic Adenovirus Delta-24-RGDOX After Intratumoral Adoptive T-cell Therapy Promotes Antigen Spread to Sustain Systemic Antitumor Immunity.
    Jiang H; Shin DH; Yi Y; Fan X; Gumin J; He J; Gillard AG; Lang FF; Gomez-Manzano C; Fueyo J
    Cancer Res Commun; 2023 Jun; 3(6):1118-1131. PubMed ID: 37379361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localized Treatment with Oncolytic Adenovirus Delta-24-RGDOX Induces Systemic Immunity against Disseminated Subcutaneous and Intracranial Melanomas.
    Jiang H; Shin DH; Nguyen TT; Fueyo J; Fan X; Henry V; Carrillo CC; Yi Y; Alonso MM; Collier TL; Yuan Y; Lang FF; Gomez-Manzano C
    Clin Cancer Res; 2019 Nov; 25(22):6801-6814. PubMed ID: 31455679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncolytic Adenovirus and Tumor-Targeting Immune Modulatory Therapy Improve Autologous Cancer Vaccination.
    Jiang H; Rivera-Molina Y; Gomez-Manzano C; Clise-Dwyer K; Bover L; Vence LM; Yuan Y; Lang FF; Toniatti C; Hossain MB; Fueyo J
    Cancer Res; 2017 Jul; 77(14):3894-3907. PubMed ID: 28566332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reshaping the tumor microenvironment with oncolytic viruses, positive regulation of the immune synapse, and blockade of the immunosuppressive oncometabolic circuitry.
    Nguyen TT; Shin DH; Sohoni S; Singh SK; Rivera-Molina Y; Jiang H; Fan X; Gumin J; Lang FF; Alvarez-Breckenridge C; Godoy-Vitorino F; Zhu L; Zheng WJ; Zhai L; Ladomersky E; Lauing KL; Alonso MM; Wainwright DA; Gomez-Manzano C; Fueyo J
    J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35902132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination viroimmunotherapy with checkpoint inhibition to treat glioma, based on location-specific tumor profiling.
    Cockle JV; Rajani K; Zaidi S; Kottke T; Thompson J; Diaz RM; Shim K; Peterson T; Parney IF; Short S; Selby P; Ilett E; Melcher A; Vile R
    Neuro Oncol; 2016 Apr; 18(4):518-27. PubMed ID: 26409567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GITRL-armed Delta-24-RGD oncolytic adenovirus prolongs survival and induces anti-glioma immune memory.
    Rivera-Molina Y; Jiang H; Fueyo J; Nguyen T; Shin DH; Youssef G; Fan X; Gumin J; Alonso MM; Phadnis S; Lang FF; Gomez-Manzano C
    Neurooncol Adv; 2019; 1(1):vdz009. PubMed ID: 31608328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erratum: Gut microbiota composition is associated with the efficacy of Delta-24-RGDOX in malignant gliomas.
    Meléndez-Vázquez NM; Nguyen TT; Fan X; López-Rivas AR; Fueyo J; Gomez-Manzano C; Godoy-Vitorino F
    Mol Ther Oncol; 2024 Jun; 32(2):200801. PubMed ID: 38681802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncolytic herpes simplex virus expressing IL-2 controls glioblastoma growth and improves survival.
    Bommareddy PK; Wakimoto H; Martuza RL; Kaufman HL; Rabkin SD; Saha D
    J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38599661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bifidobacterium affects antitumor efficacy of oncolytic adenovirus in a mouse model of melanoma.
    Tripodi L; Feola S; Granata I; Whalley T; Passariello M; Capasso C; Coluccino L; Vitale M; Scalia G; Gentile L; De Lorenzo C; Guarracino MR; Castaldo G; D'Argenio V; Szomolay B; Cerullo V; Pastore L
    iScience; 2023 Oct; 26(10):107668. PubMed ID: 37720092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An immune-competent, replication-permissive Syrian Hamster glioma model for evaluating Delta-24-RGD oncolytic adenovirus.
    Phillips LM; Li S; Gumin J; Daou M; Ledbetter D; Yang J; Singh S; Parker Kerrigan BC; Hossain A; Yuan Y; Gomez-Manzano C; Fueyo J; Lang FF
    Neuro Oncol; 2021 Nov; 23(11):1911-1921. PubMed ID: 34059921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysbiosis of Gut Microbiota Contributes to Uremic Cardiomyopathy via Induction of IFNγ-Producing CD4
    Han B; Zhang X; Wang L; Yuan W
    Microbiol Spectr; 2023 Feb; 11(1):e0310122. PubMed ID: 36788674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD137 and PD-L1 targeting with immunovirotherapy induces a potent and durable antitumor immune response in glioblastoma models.
    Puigdelloses M; Garcia-Moure M; Labiano S; Laspidea V; Gonzalez-Huarriz M; Zalacain M; Marrodan L; Martinez-Velez N; De la Nava D; Ausejo I; Hervás-Stubbs S; Herrador G; Chen Z; Hambardzumyan D; Patino Garcia A; Jiang H; Gomez-Manzano C; Fueyo J; Gállego Pérez-Larraya J; Alonso M
    J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34281988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Convection-enhanced delivery of temozolomide and whole cell tumor immunizations in GL261 and KR158 experimental mouse gliomas.
    Enríquez Pérez J; Kopecky J; Visse E; Darabi A; Siesjö P
    BMC Cancer; 2020 Jan; 20(1):7. PubMed ID: 31900109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eliciting an immune-mediated antitumor response through oncolytic herpes simplex virus-based shared antigen expression in tumors resistant to viroimmunotherapy.
    Ghonime MG; Saini U; Kelly MC; Roth JC; Wang PY; Chen CY; Miller K; Hernandez-Aguirre I; Kim Y; Mo X; Stanek JR; Cripe T; Mardis E; Cassady KA
    J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34599026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic cellular viroimmunotherapy for canine high-grade gliomas.
    Cloquell A; Mateo I; Gambera S; Pumarola M; Alemany R; García-Castro J; Perisé-Barrios AJ
    J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36600663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjunctive Probiotic
    Gao G; Ma T; Zhang T; Jin H; Li Y; Kwok LY; Zhang H; Sun Z
    Front Immunol; 2021; 12():772532. PubMed ID: 34970262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunovirotherapy with measles virus strains in combination with anti-PD-1 antibody blockade enhances antitumor activity in glioblastoma treatment.
    Hardcastle J; Mills L; Malo CS; Jin F; Kurokawa C; Geekiyanage H; Schroeder M; Sarkaria J; Johnson AJ; Galanis E
    Neuro Oncol; 2017 Apr; 19(4):493-502. PubMed ID: 27663389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of gut microbiota in patients with benign and malignant brain tumors: a pilot study.
    Jiang H; Zeng W; Zhang X; Pei Y; Zhang H; Li Y
    Bioengineered; 2022 Mar; 13(3):7847-7859. PubMed ID: 35291914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chimeric oncolytic adenovirus evades neutralizing antibodies from human patients and exhibits enhanced anti-glioma efficacy in immunized mice.
    Shin DH; Jiang H; Gillard AG; Kim D; Fan X; Singh SK; Nguyen TT; Sohoni SS; Lopez-Rivas AR; Parthasarathy A; Ene CI; Gumin J; Lang FF; Alonso MM; Gomez-Manzano C; Fueyo J
    Mol Ther; 2024 Mar; 32(3):722-733. PubMed ID: 38311852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.